Portfolio (Quarterly)
Guide ↗
SUPERSTRING CAPITAL MANAGEMENT LP
· CIK 0001931118| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SMMT | SUMMIT THERAPEUTICS INC | Healthcare | 892,873.0 | $16.9M | 12.10% | NEW | — | $18.96 | -5.6% |
| 2 | IMVT | IMMUNOVANT INC | Healthcare | 357,606.0 | $8.9M | 6.35% | +69K | +23.9% | $24.84 | +37.4% |
| 3 | COGT | COGENT BIOSCIENCES INC | Healthcare | 225,158.0 | $8.7M | 6.19% | -141K | -38.5% | $38.49 | -15.4% |
| 4 | SVRA | SAVARA INC | Healthcare | 1,585,977.0 | $8.7M | 6.19% | +591K | +59.3% | $5.46 | -7.0% |
| 5 | URGN | UROGEN PHARMA LTD | Healthcare | 387,371.0 | $7.0M | 4.98% | -331K | -46.1% | $17.98 | +68.1% |
| 6 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 351,461.0 | $6.6M | 4.75% | NEW | — | $18.90 | +19.8% |
| 7 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 730,548.0 | $6.5M | 4.68% | NEW | — | $8.96 | -0.9% |
| 8 | PCVX | VAXCYTE INC | Healthcare | 110,454.0 | $6.4M | 4.59% | NEW | — | $58.11 | -18.4% |
| 9 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 180,048.0 | $5.7M | 4.08% | +92K | +103.9% | $31.72 | -3.6% |
| 10 | SION | SIONNA THERAPEUTICS INC | Healthcare | 141,024.0 | $5.7M | 4.04% | -40K | -21.9% | $40.09 | -1.5% |
| 11 | GMAB | GENMAB A/S | Healthcare | 196,709.0 | $5.3M | 3.77% | +168K | +574.5% | $26.83 | +0.8% |
| 12 | ZLAB | ZAI LAB LTD | Healthcare | 275,818.0 | $5.2M | 3.71% | +79K | +40.1% | $18.81 | -0.0% |
| 13 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 11,010.0 | $4.9M | 3.51% | NEW | — | $446.54 | -3.6% |
| 14 | — | IQVIA HLDGS INC | — | 25,668.0 | $4.4M | 3.13% | NEW | — | $170.54 | — |
| 15 | MPLT | MAPLIGHT THERAPEUTICS INC | Healthcare | 192,139.0 | $3.9M | 2.79% | NEW | — | $20.33 | +44.0% |
| 16 | ARVN | ARVINAS INC | Healthcare | 312,620.0 | $3.3M | 2.37% | NEW | — | $10.60 | -14.2% |
| 17 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 63,591.0 | $3.1M | 2.23% | NEW | — | $49.05 | +19.7% |
| 18 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 5,186.0 | $3.1M | 2.20% | -4K | -45.1% | $592.98 | -4.9% |
| 19 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 102,754.0 | $3.1M | 2.18% | +65K | +170.2% | $29.71 | +46.4% |
| 20 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 251,566.0 | $3.0M | 2.14% | +103K | +69.6% | $11.93 | +16.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%